Piepoli MF, Hoes AW, Agewall S, et al; Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Accessed 29 Jun 2016. PMID: 27222591
Ministry of Health (MOH) Malaysia. Prevention of cardiovascular disease in women 2016. 2nd ed. MOH Malaysia. http://www.moh.gov.my. 2016. Accessed 21 Mar 2017.
Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2017 Apr;23(4):479-497. doi: 10.4158/EP171764.GL. Accessed 23 Mar 2017. PMID: 28156151
Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2016 Jul;68(1):92-125. doi: 10.1016/j.jacc.2016.03.519. Accessed 21 Mar 2017. PMID: 27046161
Siscovick DS, Barringer TA, Fretts AM, et al; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Omega-3 polyunsaturated fatty acid (Fish Oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2017 Apr 11;135(15):e867-e884. doi: 10.1161/CIR.0000000000000482. Accessed 23 Mar 2017. PMID: 28289069
St-Onge MP, Ard J, Baskin ML, et al; American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2017 Feb;135(9):e96-e121. doi: 10.1161/CIR.0000000000000476. Accessed 21 Mar 2017. PMID: 28137935
Cheung BM, Cheng CH, Lau CP, et al. 2016 Consensus statement on prevention of atherosclerotic cardiovascular disease in the Hong Kong population. Hong Kong Med J. 2017 Apr;23(2):191-201. doi: 10.12809/hkmj165045. Accessed 01 Aug 2017. PMID: 28387202
Dehghan M, Mente A, Zhang X, et al; Prospective Urban Rural Epidemiology (PURE) study investigators. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017 Nov 4;390(10107):2050-2062. doi: 10.1016/S0140-6736(17)32252-3. Accessed 07 Sep 2017. PMID: 28864332
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Accessed 16 Nov 2017. PMID: 29146535
Ministry of Health Malaysia, Academy of Medicine Malaysia and National Heart Association of Malaysia. Clinical practice guidelines on primary & secondary prevention of cardiovascular disease 2017. Academy of Medicine Malaysia. http://www.acadmed.org.my. 2017. Accessed 18 Dec 2017.
Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:1-9. doi: 10.1177/2048004016687211. Accessed 09 May 2018. PMID: 28286646
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209. doi: 10.1016/j.jacc.2018.11.002. Accessed 29 Jan 2019. PMID: 30423391
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Accessed 18 Mar 2019. PMID: 30879355
Das SR, Everett BM, Birtcher KK et al. 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Accessed 19 Feb 2019. PMID: 30497881
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Society of Cardiology (ESC). http://www.escardio.org. 31 Aug 2019. Accessed 03 Mar 2023.
Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Society of Cardiology (ESC). http://www.escardio.org. 31 Aug 2019. Accessed 10 Sep 2019.
Centers for Disease Control and Prevention (CDC). People with certain medical conditions. CDC. https://www.cdc.gov/. 03 Feb 2021. Accessed 22 Feb 2021.
Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Accessed 22 Feb 2021. PMID: 32200663
Doupis J, Avramidis K. Managing diabetes during the COVID-19 pandemic. Eur Endocrinol. 2020 Oct;16(2):85–87. doi: 10.17925/EE.2020.16.2.85. PMID: 33117436
Iqbal Z, Ho JH, Adam S, et al. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: an expert panel position statement from HEART UK. Atherosclerosis. 2020 Nov;313:126-136. doi: 10.1016/j.atherosclerosis.2020.09.008. Accessed 18 Jan 2021. PMID: 33045618
Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular disease and coronavirus disease 2019: epidemiology, management, and prevention. Curr Epidemiol Rep. 2021 Jan 2:1-8. doi: 10.1007/s40471-020-00261-2. Accessed 22 Feb 2021. PMID: 33425654
Lim S, Bae JH, Kwon HS, et al. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021 Jan;17(1):11-30. doi: 10.1038/s41574-020-00435-4. Accessed 22 Feb 2021. PMID: 33188364
Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021 Mar;17(3):135-149. doi: 10.1038/s41574-020-00462-1. PMID: 33479538
European Society for Cardiology (ESC). ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. ESC. https://www.escardio.org. 10 Jun 2020. Accessed 22 Feb 2021.
McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Accessed 15 Dec 2021. PMID: 34447992
Visseren FLJ, Mach F, Smulders YM, et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Accessed 15 Dec 2021. PMID: 34458905
The Task Force for the Management of COVID-19 of the European Society of Cardiology (ESC). ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-1103. doi: 10.1093/eurheartj/ehab697. Accessed 28 May 2022. PMID: 34791154
Writing Committee; Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 Aug 23;S0735-1097(22)05594-2. doi: 10.1016/j.jacc.2022.07.006. Accessed 01 Sep 2022. PMID: 36031461
American Diabetes Association. Standards of care in diabetes - 2023. Diabetes Care. 2023 Jan;46(Suppl 1):S1-S280. https://diabetesjournals.org/. Accessed 05 Jun 2023. PMID: 36507639
Pearson GJ, Thanassoulis G, Anderson TJ, et al. 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Accessed 10 Jan 2023. PMID: 33781847
Hennekens CH. Overview of primary prevention of cardiovascular disease in adults. UpToDate. https://www.uptodate.com. 24 Sep 2024. Accessed 17 Mar 2023.
Hennekens CH, Lopez-Sendon J. Prevention of cardiovascular disease events in those with established disease (secondary prevention). UpToDate. https://www.uptodate.com. 02 Jan 2025. Accessed 17 Mar 2023.
Periodic Health Examination Task Force 2021. Philippine guidelines on periodic health examination. Screening for cardiovascular disease. Republic of the Philippines Department of Health. https://doh.gov.ph/. 2022.
U.S. Food & Drug Administration (US FDA). Lodoco highlights of prescribing information. US FDA. https://www.accessdata.fda.gov. Jun 2023. Accessed 26 Jun 2023.
Marx N, Federici M, Schutt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Aug 25;ehad192. doi: 10.1093/eurheartj/ehad192. Accessed 04 Sep 2023. PMID: 37622663
National Institute for Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE. https://www.nice.org.uk/guidance/ng238. 14 Dec 2023. Accessed 02 Apr 2024.
Vemu PL, Yang E, Ebinger J. 2023 ESH hypertension guideline update: bringing us closer together across the pond. American College of Cardiology. https://www.acc.org. 05 Feb 2024. Accessed 01 Jul 2024.
